CDH2 and cancer: The epithelial-to-mesenchymal transition (EMT) enhances the mobility of cancer cells, facilitating their distant metastasis [21], showing suppression of epithelial markers, such as E-cadherin, as well as the overexpression of mesenchymal markers, such as N-cadherin and Vimentin.